Skip to main content
. 2018 Oct 28;27(2):542–550. doi: 10.1016/j.jfda.2018.09.007

Fig. 2.

Fig. 2

PON-1 carbamylation increased in uremia patients. (A) Immune precipitated carbamylated HDL proteins then blotted the precipitated proteins with anti-PON-1 antibody revealed a higher density of carbamylated PON-1 in uremia patients than in control subjects. (B) Immune precipitated PON-1 from HDL then blotted the precipitated PON-1 with anti-carbamyl antibody (anti-CBL) showed a higher concentration of carbamylated PON-1 in uremia patients than in control subjects. (C) Sandwich study of carbamylated PON-1 showed the concentration of carbamylated PON-1 in HDL was higher in uremia patients (n = 16) than in control subjects (n = 16). *,p < 0.05.